Lipitor Diabetes Lawsuit News: Lawsuits Increasing Rapidly
In a little over one month, nearly 200 new Lipitor diabetes lawsuits have been filed in a federal litigation currently underway in the U.S. District Court, District of South Carolina on behalf of patients who allegedly developed type 2 diabetes after using Lipitor, a statin medication.
The U.S. Judicial Panel on Multidistrict Litigation released an update on April 15, 2014 which noted a total of 464 Lipitor diabetes lawsuits alleging new-onset conditions are now pending in the federal proceeding. The JPML’s most recent updates represents significant growth in the federal litigation as a previous update on March 31, 2014 indicated that only 270 Lipitor diabetes lawsuits had been filed at that time.
According to court records, these Lipitor diabetes lawsuits were filed on behalf of plaintiffs who allege that Pfizer Inc., the manufacturer of Lipitor, failed to adequately warn the public and medical communities of Lipitor’s potential to cause type 2 diabetes and concealed knowledge of the potential dangers to protect sales of the medication.
Lipitor lawsuits began to increase shortly after the U.S. Food and Drug Administration issued a public health alert regarding a possible association between statin medications such as Lipitor and diabetes. The warning, published in February 2012, followed the findings of a study released in January 2012 in the Journal of the American Medical Association that reported that post-menopausal women taking Lipitor and other statin drugs were more likely to develop type 2 diabetes than those who were not using the medication at all.
As a result, the FDA required all manufacturers of statin medications to revise the labels on their products to reflect the possible link with type 2 diabetes. However, plaintiffs filing Lipitor lawsuits allege that the information added to the product’s label is still insufficient.
Another study published by the British Medical Journal in May 2013 provided additional evidence to a potential link between diabetes and Lipitor when researchers found that patients taking the generic version of Lipitor were 22 percent more likely to develop type 2 diabetes than those who did not use the drug.
Those who have allegedly developed type 2 diabetes while using Lipitor may be able to seek compensation for pain and suffering, lost wages and out-of-pocket medical expenses that they may have incurred as a result of the situation.
Do You have a Lipitor Diabetes Lawsuit?
If you or someone you love took Lipitor and you were diagnosed with diabetes, contact the American Injury Attorney Group today to learn more about filing a Lipitor diabetes lawsuit and recovering damages for your injuries. We can review your case at no cost to you and help determine if you have a case. We can connect you with an affiliated attorney who can file your Lipitor diabetes lawsuit on your behalf and help you seek compensation to which you may be entitled.